MALIGNANT NEOPLASMS
Clinical trials for MALIGNANT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Groundbreaking oral cancer treatment enters first human testing
Disease control Recruiting nowThis is the first human study of a new oral medication called DEG6498 for people with advanced solid tumors that haven't responded to standard treatments. Researchers will test different doses in about 100 participants to find the safest amount and monitor for side effects. The s…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Degron Therapeutics Co. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for advanced kidney cancer patients in Second-Line treatment trial
Disease control Recruiting nowThis study is testing whether adding a new drug called SLC-3010 to an existing cancer drug (axitinib) works better than using axitinib alone. It is for adults with advanced kidney cancer that has worsened after their first treatment. The main goal is to see if the combination hel…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill combo targets tough cancers in early trial
Disease control Recruiting nowThis early-stage study is testing the safety and initial effects of a new oral medicine, PF-07799544, when taken with another drug, PF-07799933. It is for adults with advanced solid tumors, like melanoma or lung cancer, that have a specific genetic change called a BRAF V600 mutat…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC
-
Scientists gather cancer clues to build future cures
Knowledge-focused Recruiting nowThis study collects blood, urine, and tissue samples from people with or suspected of having cancers of the kidney, bladder, prostate, and other urinary system cancers. The samples are stored in a tissue bank and used for research to understand the genetic causes of these cancers…
Matched conditions: MALIGNANT NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC